DUBOVSKY FILIP 1977361 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-21 | 2023-06-16 | 2023-06-16 | 4 | Dubovsky Filip | PRESIDENT, R&D | dsp | 2007.0 | 4.26 | 0.23 | 8.04 | Direct | Common Stock | NOVAVAX INC | code F | 45058.0 | 86.31 (NVAX) |
| 2023-06-21 | 2023-06-16 | 2023-06-16 | 4 | Dubovsky Filip | PRESIDENT, R&D | acq | 4155.0 | 8.83 | 0.48 | 8.04 | Direct | Common Stock | NOVAVAX INC | code M | 47065.0 | 86.31 (NVAX) |
| 2023-06-21 | 2023-06-16 | 3 | Dubovsky Filip | PRESIDENT, R&D | holding | 42910.0 | 0 | 4.97 | 0.0 | Direct | Common Stock | NOVAVAX INC | NA | 86.31 (NVAX) | ||
| 2023-09-19 | 2023-09-16 | 2023-09-16 | 4 | Dubovsky Filip | PRESIDENT, R&D | dsp | 6108.0 | 10.59 | 0.65 | 7.71 | Direct | Common Stock | NOVAVAX INC | code F | 51594.0 | 94.4 (NVAX) |
| 2023-09-19 | 2023-09-16 | 2023-09-16 | 4 | Dubovsky Filip | PRESIDENT, R&D | acq | 12644.0 | 21.91 | 1.34 | 7.71 | Direct | Common Stock | NOVAVAX INC | code M | 57702.0 | 94.4 (NVAX) |
| 2023-11-07 | 2023-11-05 | 2023-11-05 | 4 | Dubovsky Filip | PRESIDENT, R&D | acq | 1400.0 | 2.64 | 0.15 | 7.06 | Direct | Common Stock | NOVAVAX INC | code M | 52994.0 | 94.4 (NVAX) |
| 2023-11-07 | 2023-11-05 | 2023-11-05 | 4 | Dubovsky Filip | PRESIDENT, R&D | dsp | 677.0 | 1.28 | 0.07 | 7.06 | Direct | Common Stock | NOVAVAX INC | code F | 52317.0 | 94.4 (NVAX) |
| 2023-12-18 | 2023-12-14 | 2023-12-14 | 4 | Dubovsky Filip | PRESIDENT, R&D | acq | 2833.0 | 5.14 | 0.24 | 5.69 | Direct | Common Stock | NOVAVAX INC | code M | 55150.0 | 118.79 (NVAX) |
| 2023-12-18 | 2023-12-14 | 2023-12-14 | 4 | Dubovsky Filip | PRESIDENT, R&D | dsp | 1368.0 | 2.48 | 0.12 | 5.69 | Direct | Common Stock | NOVAVAX INC | code F | 53782.0 | 118.79 (NVAX) |
| 2024-03-11 | 2024-03-07 | 2024-03-07 | 4 | Dubovsky Filip | PRESIDENT, R&D | acq | 19444.0 | 26.55 | 1.39 | 0.0 | Direct | Common Stock | NOVAVAX INC | code M | 73226.0 | 139.95 (NVAX) |
| 2024-03-11 | 2024-03-07 | 2024-03-07 | 4 | Dubovsky Filip | PRESIDENT, R&D | dsp | 9392.0 | 12.83 | 0.67 | 5.61 | Direct | Common Stock | NOVAVAX INC | code F | 63834.0 | 139.95 (NVAX) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Dubovsky Filip | PRESIDENT, R&D | dsp | 2597.0 | 3.75 | 0.19 | 5.45 | Direct | Common Stock | NOVAVAX INC | code F | 66613.0 | 139.95 (NVAX) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Dubovsky Filip | PRESIDENT, R&D | acq | 5376.0 | 7.77 | 0.38 | 0.0 | Direct | Common Stock | NOVAVAX INC | code M | 69210.0 | 139.95 (NVAX) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-21 | 2023-06-16 | 2023-06-16 | 4 | Dubovsky Filip | PRESIDENT, R&D | dsp | 4155.0 | 100.0 | 0.48 | 0.0 | Direct | Restricted Stock Units | NOVAVAX INC | code M | 0.0 | 86.31 (NVAX) |
| 2023-06-21 | 2023-06-16 | 3 | Dubovsky Filip | PRESIDENT, R&D | holding | 90114.0
|
0 | 10.44 | 0.0 | Direct | Restricted Stock Units | NOVAVAX INC | NA | 86.31 (NVAX) | ||
| 2023-06-21 | 2023-06-16 | 3 | Dubovsky Filip | PRESIDENT, R&D | holding | 169323.0
|
0 | 19.62 | 0.0 | Direct | Stock Option (Right To Buy) | NOVAVAX INC | NA | 86.31 (NVAX) | ||
| 2023-09-19 | 2023-09-16 | 2023-09-16 | 4 | Dubovsky Filip | PRESIDENT, R&D | dsp | 12644.0 | 100.0 | 1.34 | 0.0 | Direct | Restricted Stock Units | NOVAVAX INC | code M | 0.0 | 94.4 (NVAX) |
| 2023-11-07 | 2023-11-05 | 2023-11-05 | 4 | Dubovsky Filip | PRESIDENT, R&D | dsp | 1400.0 | 100.0 | 0.15 | 0.0 | Direct | Restricted Stock Units | NOVAVAX INC | code M | 0.0 | 94.4 (NVAX) |
| 2023-12-18 | 2023-12-14 | 2023-12-14 | 4 | Dubovsky Filip | PRESIDENT, R&D | dsp | 2833.0 | 100.0 | 0.24 | 0.0 | Direct | Restricted Stock Units | NOVAVAX INC | code M | 0.0 | 118.79 (NVAX) |
| 2024-03-11 | 2024-03-07 | 2024-03-07 | 4 | Dubovsky Filip | PRESIDENT, R&D | dsp | 19444.0 | 100.0 | 1.39 | 0.0 | Direct | Restricted Stock Units | NOVAVAX INC | code M | 0.0 | 139.95 (NVAX) |
| 2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Dubovsky Filip | PRESIDENT, R&D | dsp | 5376.0 | 50.0 | 0.38 | 0.0 | Direct | Restricted Stock Units | NOVAVAX INC | code M | 5376.0 | 139.95 (NVAX) |
| 2024-03-26 | 2024-03-01 | 2024-03-01 | 4 | Dubovsky Filip | PRESIDENT, R&D | acq | 144000.0 | 100.0 | 10.29 | 0.0 | Direct | Restricted Stock Units | NOVAVAX INC | code A | 144000.0 | 139.95 (NVAX) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)